Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

52 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NCT06271252

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Recruiting

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NCT05573802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic Athens, Greece

Anticancer Hospital of Thessaloniki "Theageneio" Thessaloniki, Greece

View Trial Details

Enrolling by Invitation

This Study Aims to Investigate the Efficacy of Photobiomodulation in the Treatment of Anti-MAG-induced Peripheral Neuropathy (LASER-MAG)

NCT07661667

Conditions: Anti MAG Neuropathy, Blood Protein Disorders, Hematologic Diseases, +7 more
Locations: Centre hospitalier de Cornouaille Quimper, France

View Trial Details

Enrolling by Invitation

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

NCT04210791

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +14 more
Locations: National Clinical Research Center of Kidney Diseases, Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging

NCT07624760

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
Locations: University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not Yet Recruiting

Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders

NCT07365059

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Multi-center Screening for Serum M Protein

NCT06750965

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.

NCT06489613

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

NCT05581875

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: Not specified

View Trial Details

Completed

Rifaximin in Patients With Monoclonal Gammopathy

NCT03820817

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Gammopathy Igg, +21 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions